Deutsche Bank Ag\ Fennec Pharmaceuticals Inc. Transaction History

Deutsche Bank Ag\

$212 Billion
Q1 2024

A detailed history of Deutsche Bank Ag\ transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 12,313 shares of FENC stock, worth $74,247. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,313

Previous 11,311 8.86%

Holding current value

$74,247

Previous $126,000 7.94%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.82 - $11.12 $8,837 - $11,142	1,002 Added 8.86%	12,313 $136,000
Q4 2023 Feb 14, 2024	BUY	$6.48 - $11.61 $73,295 - $131,320	11,311 New	11,311 $126,000
Q3 2021 Nov 04, 2021	SELL	$6.51 - $9.62 $19,972 - $29,514	-3,068 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$5.96 - $7.85 $72,312 - $95,244	-12,133 Reduced 79.82%	3,068 $22,000
Q1 2021 May 13, 2021	SELL	$6.21 - $8.68 $8,234 - $11,509	-1,326 Reduced 8.02%	15,201 $0

Q4 2020 Feb 16, 2021	BUY	$5.99 - $8.55 $25,768 - $36,782	4,302 Added 35.19%	16,527 $123,000
Q3 2020 Nov 12, 2020	BUY	$5.19 - $10.17 $5,454 - $10,688	1,051 Added 9.41%	12,225 $74,000
Q2 2020 Aug 13, 2020	BUY	$5.43 - $9.39 $60,674 - $104,923	11,174 New	11,174 $93,000
Q1 2020 May 14, 2020	SELL	$4.89 - $8.1 $6,811 - $11,283	-1,393 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.25 - $6.49 $5,920 - $9,040	1,393 New	1,393 $9,000
Q3 2019 Nov 14, 2019	SELL	$3.85 - $4.95 $10,818 - $13,909	-2,810 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$3.3 - $5.09 $142,992 - $220,554	-43,331 Reduced 93.91%	2,810 $11,000
Q1 2019 May 15, 2019	BUY	$4.64 - $7.58 $144,178 - $235,533	31,073 Added 206.22%	46,141 $222,000
Q4 2018 Feb 14, 2019	SELL	$5.37 - $8.39 $60,219 - $94,085	-11,214 Reduced 42.67%	15,068 $95,000
Q3 2018 Dec 21, 2021	BUY	$7.84 - $10.83 $23,927 - $33,053	3,052 Added 13.14%	26,282 $215,000
Q3 2018 Nov 14, 2018	SELL	$7.84 - $10.83 $51,061 - $70,535	-6,513 Reduced 21.9%	23,230 $190,000
Q2 2018 Apr 21, 2020	BUY	$10.05 - $14.33 $36,913 - $52,634	3,673 Added 14.09%	29,743 $310,000
Q2 2018 Aug 14, 2018	SELL	$10.05 - $14.33 $27,547 - $39,278	-2,741 Reduced 9.51%	26,070 $271,000
Q1 2018 Oct 18, 2019	SELL	$8.26 - $12.1 $41 - $60	-5 Reduced 0.02%	28,811 $348,000
Q1 2018 May 15, 2018	BUY	$8.26 - $12.1 $233,031 - $341,365	28,212 Added 4670.86%	28,816 $348,000
Q4 2017 Feb 14, 2018	BUY	$8.9 - $12.35 $5,331 - $7,397	599 Added 11980.0%	604 $6,000
Q3 2017 Nov 14, 2017	BUY	$11.09 - $12.0 $55 - $60	5	5 $0

Others Institutions Holding FENC

# of Institutions

Shares Held

14.4M

Call Options Held

53.2K

Put Options Held

83.9K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $157M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account